• Overview
  • Eligibility
  • More info
  • Locations

Internet Intervention for Sun Protection and Skin Self-check Behaviors (NCT03028948)

National Cancer Institute (NCI)
University of Virginia
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
  • Other: Internet-Based Intervention
    Access ITW
    • Other: Questionnaire Administration
      Ancillary studies
      • Other: Survey Administration
        Ancillary studies
        Ages eligible for Study
        18 Years and older
        Genders eligible for Study
        All
        Accepts Healthy Volunteers
        No
        PRIMARY OBJECTIVES:

        I. To evaluate the impact of the interactive tailored website (ITW) versus usual care on skin self-examination (SSE) and sun protection behaviors among individuals diagnosed with melanoma.

        SECONDARY OBJECTIVES:

        I. To examine mediators of the impact of the intervention. The effects of the intervention on SSE and sun protection behaviors will be mediated by melanoma knowledge, self-efficacy for SSE and sun protection behaviors, perceived benefits of SSE and sun protection behaviors, perceived barriers to SSE and sun protection behaviors, and perceived controllability of melanoma.

        TERTIARY OBJECTIVES:

        I. To examine moderators of the impact of the intervention. To evaluate whether ITW effects are moderated by the following factors: time since diagnosis, disease stage, age, sex, income, education, Internet experience, distress about melanoma, worry about recurrence, and evaluation and usage of the ITW.

        OUTLINE:

        Phase I: Patients review draft website content materials in a semi-structured format and provide feedback via open- and closed-ended questions for the development, testing, and finalization of ITW.

        Phase II: Patients are randomized into 1 of 2 arms.

        ARM I: Patients access ITW and complete each module over 30-40 minutes.

        ARM II: Patients receive usual care and are then offered ITW.

        All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.

        2 locations

        United States (2)
        • Rutgers Cancer Institute of New Jersey
          recruiting
          New Brunswick, New Jersey, United States, 08903
        • University of Virginia
          not yet recruiting
          Charlottesville, Virginia, United States, 22904
        Status:
        recruiting
        Type:
        Interventional
        Phase:
        -
        Start:
        12 March, 2017
        Updated:
        03 April, 2017
        Participants:
        420
        Apply
        A girl giving information about available additional trials.

        FindMeCure helps you find, understand and join clinical trials from all over the world.

        There are more clinical trials for your condition!